Omnicell Inc., a Mountainview based leading provider of medication and supply management solutions to healthcare systems, has announced the acquisition of SurgiChem Limited, a provider of medication adherence packaging systems and solutions across United Kingdom.
SurgiChem is based in Stockport and has 21 employees. Company is a wholly owned subsidiary of Bupa Care Homes plc. It provides medication adherence packaging systems and solutions across the country. Bupa is an international healthcare group serving over 14 million customers across 190 countries. It has 62,000 employees across various countries.
Omnicell's medication automation and analytic solution has been used by over 2,700 customers worldwide. It helps in reducing errors, improving operational efficiency, deliver actionable intelligence and improve patient safety. Its MTS Medication Technologies brand is a non-acute care solution. It helps pharmacies to maintain high accuracy and quality standards in medication dispensing and administration.
As medication non-adherence is a major healthcare problem across the countries. As per Omnicell's management both companies' products are complimentary to each other. Therefore, both products will be bundled together, to reduce medication errors and lower costs by effectively managing adherence.
No comments:
Post a Comment